Drew Ivan, chief product and strategy officer, and Jessica Nisenbaum, chief people officer, both with Rhapsody, discuss the benefits and challenges of introducing patient-generated health data into practice, and explain crucial moments and concepts throughout the transition process that health executives should look out for.
Read the full transcript and listen to the podcast here.
Rhapsody Health Solutions Team
Poor quality person data leads to flawed analytics, compliance risks, and lost trust. A next-gen EMPI ensures accuracy, compliance, and growth at scale.
Lynn Stoltz, Senior Product Manager
Evaluating EMPI solutions? Ask yourself these 8 questions before making a choice.
Drew Ivan, Chief Architect
There’s hesitancy around using AI in healthcare, especially when people equate the general term with generative AI instead of trusted, traditional technologies.